4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Mineralys Therapeutics, Inc. (MLYS) operates in the Biotechnology industry and is headquartered in Radnor, United States with about 76 employees. Its market capitalization is roughly $3 billion. In the fiscal year ended 2025-12-31, MLYS reported $0M in revenue and ($155M) in net income.
Mineralys Therapeutics, Inc., a biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($171M) | ($192M) | ($85M) | ($32M) | — |
| Net Income | ($155M) | ($178M) | ($72M) | ($30M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($45M) | ($38M) | ($41M) | ($47M) | ($44M) | — |
| Net Income | ($39M) | ($32M) | ($37M) | ($43M) | ($42M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $662M | $206M | $252M | $114M | — |
| Total Liabilities | $15M | $15M | $10M | $167M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MLYS viewer.
About TickerBase · Data methodology & sources